CDKN2A and Hepatic fibrosis: Since pro-inflammatory mediators serve as a driving force for HSC activation, it is conceivable that the observed amelioration of liver fibrosis as a result of p16 deficiency could be attributed to a defect in macrophage-mediated inflammation.